Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, An Issue of Interventional Cardiology Clinics

In this issue of <i>Interventional Cardiology Clinics</i>, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of <b>Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions</b>. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y₁₂ inhibitors and clinical implications; switching P2Y₁₂ receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.<ul><li>Contains <b>13 relevant, practice-oriented topics</b> including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more.</li><li>Provides in-depth <b>clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions</b>, offering actionable insights for clinical practice.</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.</li></ul>